LAURA INGRAHAM (HOST): And speaking of mistrust, Dr. Oskoui, a peer-reviewed study being published this month found that 84% fewer COVID hospitalizations among patients treated early with hydroxychloroquine and azithromycin. So think about where we all were back in April talking about HCQ. We're derided, we're trashed. It was all false. How detrimental was the media politicization of hydroxychloroquine as a therapeutic?
DR. RAMIN OSKOUI (CARDIOLOGIST): Well, I think in the United States it probably led to, according to Dr. Risch, probably over 100,000 deaths that could've been easily avoided. But it's had more broad implications. What's happened is that we never developed in the United States, unlike almost every other second- and third-world country, a way of preventing patients from going to the hospital, developing an early ambulatory care protocol, using either hydroxychloroquine or Ivermectin, which have been both very successful and very safely used in most of the world. And because of that, we've stressed our health care system, we've almost crashed our economy, and we've destroyed small business, and potentially, sadly, we may have really wounded ourselves from a military standpoint and a health care standpoint for years to come.